Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹18.65
Market cap: ₹44.22 Cr
Revenue (annual): ₹92.74 Cr
Net profit (annual): ₹4.96 Cr
P/E (TTM): 5.8×Sector 47.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Board Meeting Date 4 Annual General Meeting 4 Financial Results 3 Board Meeting Outcome 3 Management Change 2 Capacity Expansion 2 Results Update 1 Legal & Regulatory 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 May 2026 20:56 IST BSE

Results Update

Kabra Drugs Results Update

Kabra Drugs Limited reported a turnaround FY26 with ₹93.23 Crore Total Income and positive PAT. The company is expanding into pharmaceutical manufacturing and AI-led defense technologies.

Value: ₹93.23 Cr

Read the filing ↗